The potential mechanism may involve BRAF pathway inhibitors downregulating MAPK signaling, thereby reversing the immunosuppressive properties of tumor cells (e.g., by increasing CD8+ T cell infiltration) and simultaneously enhancing tumor cell-intrinsic immune-related expression. Here, BRAF is linked to neoplasm.